Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Alembic Pharmaceuticals Limited Futures - Jun 22

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Alembic Pharmaceuticals Limited F historical data, for real-time data please try another search
720.25 0.00    0.00%
30/06 - Closed. ( Disclaimer )
  • Prev. Close: 720.25
  • Open: 736.00
  • Day's Range: 720.25 - 736.80
Type:  Stock Future
Market:  India
Alembic Pharmaceuticals Limited F 720.25 0.00 0.00%

ALEMc1:NS Historical Data

 
Assess ALEMc1:NS UK share price history today. View the open price, closing price, historical highs, lows, changes and % change of the Alembic Pharmaceuticals Limited F stock price for the selected range of dates. The ALEMc1:NS share historical data can be viewed in daily, weekly or monthly time intervals. At the bottom of the table you'll find the data summary for the selected range of dates.

Investors who are logged into their free investing.com account can also benefit from exporting their chosen filtered ALEMc1:NS share price history data.
Time Frame:
20/05/2022 - 19/04/2024
 
Date Price Open High Low Vol. Change %
Jun 30, 2022 728.25 736.00 736.80 720.25 374.50K -1.49%
Jun 29, 2022 739.30 735.50 742.00 720.15 991.90K -0.09%
Jun 28, 2022 739.95 749.85 750.85 738.00 409.50K -1.46%
Jun 27, 2022 750.90 730.00 760.35 730.00 717.50K 3.24%
Jun 24, 2022 727.30 747.45 747.45 722.00 151.20K 0.08%
Jun 23, 2022 726.70 719.00 731.70 716.50 134.40K 0.95%
Jun 22, 2022 719.85 725.00 730.60 712.10 178.50K -1.34%
Jun 21, 2022 729.65 716.45 734.70 715.10 207.90K 2.62%
Jun 20, 2022 711.05 717.50 727.50 704.95 349.30K -1.40%
Jun 17, 2022 721.15 722.00 728.75 710.60 270.20K -0.50%
Jun 16, 2022 724.80 736.65 741.75 723.05 208.60K -1.80%
Jun 15, 2022 738.05 728.05 739.50 723.30 140.00K 1.26%
Jun 14, 2022 728.90 723.15 734.00 719.60 124.60K 1.03%
Jun 13, 2022 721.50 723.75 733.05 717.10 241.50K -1.67%
Jun 10, 2022 733.75 730.80 742.70 728.25 233.10K -0.03%
Jun 09, 2022 733.95 733.05 749.80 730.45 313.60K -0.13%
Jun 08, 2022 734.90 724.95 738.05 719.55 158.90K 1.58%
Jun 07, 2022 723.45 731.70 731.95 715.20 228.90K -1.28%
Jun 06, 2022 732.85 733.25 739.50 726.60 154.70K 0.24%
Jun 03, 2022 731.10 739.55 739.55 722.05 198.10K -0.25%
Jun 02, 2022 732.95 720.60 740.10 720.60 226.10K 1.28%
Jun 01, 2022 723.70 736.20 743.80 720.75 192.50K -1.34%
May 31, 2022 733.50 733.70 741.90 728.00 218.40K -0.67%
May 30, 2022 738.45 738.00 743.30 732.70 146.30K 0.44%
May 27, 2022 735.25 740.00 746.50 733.00 159.60K -0.41%
May 26, 2022 738.25 737.90 746.20 728.05 554.40K -0.17%
May 25, 2022 739.50 754.85 764.90 738.20 405.30K -2.46%
May 24, 2022 758.15 762.70 777.25 754.85 795.90K -0.57%
May 23, 2022 762.50 750.00 777.20 749.95 688.80K 0.91%
May 20, 2022 755.60 738.95 757.20 738.80 280.70K 3.76%
Highest: 777.25 Lowest: 704.95 Difference: 72.30 Average: 733.84 Change %: 0.00
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Alembic Pharmaceuticals Limited F Futures Discussion Forum

Write your thoughts about Alembic Pharmaceuticals Limited Futures
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email